Annaliesa S. Anderson

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.8K citations · Full text

Viral Diagnostics, Worldwide Outbreak, Immunology +16

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

Beate Kampmann, Shabir A. Madhi, Iona Munjal et al. · New England Journal of Medicine · 2023 · 845 citations · Full text

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults

Edward E. Walsh, Gonzalo Pérez Marc, Agnieszka Zareba et al. · New England Journal of Medicine · 2023 · 574 citations

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

A Novel <i>Staphylococcus aureus</i> Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine <i>S. aureus</i> Sepsis Model

Nelly A. Kuklin, Desmond Clark, Susan Secore et al. · Infection and Immunity · 2006 · 257 citations · Full text

Humoral Response, Immunology, Staphylococcus Aureus +21